Dr.Reddy's Laboratories,Inc.
$792.9K 68 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Kalitec Direct LLC
Kalitec Direct LLC reported $790,662.97 across General Payments, Research, and Ownership to 24 physicians and teaching hospitals across 29 transactions.
- $790.7K Above-median payer
- All-tracks total
- 29 Below-median volume
- Transactions
- 24 Below-median reach
- Recipients
- −$20.5K
- General Payments vs PY2023
Kalitec Direct LLC reported $790,662.97 across all CMS Open Payments tracks (General + Research + Ownership) to 24 physicians and teaching hospitals in Program Year 2024 - ranking #675 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $38,071.24, averaging $32.9K per recipient.
How Kalitec Direct LLC's $790.7K all-tracks total breaks down
Kalitec Direct LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
15/100
Total payments
F
17/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer kalitec-direct-llc Kalitec Direct LLC
$790.7K · #675/1,925 · 0.0% industry · PY2024
- TOT $790.7K
- RANK #675
- SHARE 0.0%
- TXN 29
- RCP 24
- CAT 2
- GEN $38.1K
- ΔGEN −$20.5K
- TOP1 30.3%
- PY 2024
Volume peers
Nearest volume peer: Dr.Reddy's Laboratories,Inc. ($792.9K)
Kalitec Direct LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Kalitec Direct LLC's CMS-reported General Payments decreased by $20.5K (−35.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: KALITEC DIRECT LLCPY2023: KALITEC DIRECT LLCPY2024: Kalitec Direct LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $58,575.33
- PY2024
- $38,071.24
What the Data Shows for Kalitec Direct LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Kalitec Direct LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Royalty or License" leads the 2-category general-payment breakdown below at $26.0K (68.2% of General Payments, 15 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Royalty or License" leads Kalitec Direct LLC's 2-category general-payment breakdown at $26.0K, 68.2% of the reported total.
How Kalitec Direct LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $26.0K | 15 | 68.2% |
| Food and Beverage | $12.1K | 9 | 31.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $37,687.55 (99.0%) of $38,071.24 in this company's General Payments records across 8 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Kalitec Direct LLC
The five named recipients with the highest reported General Payments from this company
- 1
Philip Meinhardt
$11,520.00 across 4 reported transactions
- 2
Joseph Flynn Jr
$11,380.00 across 4 reported transactions
- 3
Geoffrey Stewart
$9,580.33 across 5 reported transactions
- 4
Paul Pagano
$5,043.06 across 5 reported transactions
- 5
Theodore Belanger
$164.16 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Kalitec Direct LLC's spend rank (#675 of 1,925, top 35% by spend) and concentration rank (#630 of 1,838, top 34% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- United Medical Systems (DE), Inc. : $704.50 total payments, HHI 2641
- McKesson Sourcing Services, Inc. : $32.7K total payments, HHI 2633
- iCAD, Inc : $277.8K total payments, HHI 2628
- Aprecia Pharmaceuticals, LLC : $72.49 total payments, HHI 2625
- Carl Zeiss Meditec Cataract Technology Inc. : $122.7K total payments, HHI 2624
- Y-mAbs Therapeutics, Inc. : $208.8K total payments, HHI 2623
- Kalitec Direct LLC (this company) : $38.1K total payments, HHI 2618
- Fennec Pharmaceuticals, Inc. : $215.0K total payments, HHI 2615
- Tulsa Dental Products LLC : $2.7M total payments, HHI 2613
- MIS Implants Technologies, Inc. : $56.4K total payments, HHI 2592
- Atrium Medical Corporation : $13.1K total payments, HHI 2591
- DeGen Medical, Inc. : $324.9K total payments, HHI 2579
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Kalitec Direct LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Kalitec Direct LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Kalitec Direct LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Kyocera Medical Technologies, Inc.
$799.3K 340 recipients
Compare payment profiles
BeiGene Switzerland GmbH
$799.5K 25 recipients
Compare payment profiles
Acessa Health Inc.
$780.9K 430 recipients
Compare payment profiles
HydroCision, Inc.
$801.7K 338 recipients
Compare payment profiles
Precision Spine, Inc.
$802.9K 291 recipients
Compare payment profiles
Put this to use
Kalitec Direct LLC ranks #675 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Kalitec Direct LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.